| American Heart Association Late-Breaking Clinical Trial... |
|
Study highlights: -STEMI (heart attack) patients had fewer cardiac events with a new reversible oral anti-platelet drug compared to standard treatment with an irreversible... More »
|
|
Red Orbit - Nov. 15, 2009
|
| American Heart Association Late-Breaking Clinical Trial... |
|
Study highlights: -STEMI (heart attack) patients had fewer cardiac events with a new reversible oral anti-platelet drug compared to standard treatment with an irreversible... More »
|
|
Houston Chronicle - Nov. 15, 2009
|
| American Heart Association Late-Breaking Clinical Trial... |
|
-STEMI (heart attack) patients had fewer cardiac events with a new reversible oral anti-platelet drug compared to standard treatment with an irreversible agent. This was... More »
|
|
Sys-Con Media - Nov. 15, 2009
|
| American Heart Association Late-Breaking Clinical Trial... |
|
-STEMI (heart attack) patients had fewer cardiac events with a new reversible oral anti-platelet drug compared to standard treatment with an irreversible agent. This was... More »
|
|
Business Review Albany - Nov. 15, 2009
|
| American Heart Association Late-Breaking Clinical Trial... |
|
Study highlights: -STEMI (heart attack) patients had fewer cardiac events with a new reversible oral anti-platelet drug compared to standard treatment with an irreversible... More »
|
|
San Antonio Business Journal - Nov. 15, 2009
|
| American Heart Association Late-Breaking Clinical Trial... |
|
-STEMI (heart attack) patients had fewer cardiac events with a new reversible oral anti-platelet drug compared to standard treatment with an irreversible agent. This was... More »
|
|
Interest!ALERT - Nov. 15, 2009
|
| American Heart Association Late-Breaking Clinical Trial... |
|
-STEMI (heart attack) patients had fewer cardiac events with a new reversible oral anti-platelet drug compared to standard treatment with an irreversible agent. This was... More »
|
|
Memphis Business Journal - Nov. 15, 2009
|
| American Heart Association Late-Breaking Clinical Trial... |
|
Study highlights: -STEMI (heart attack) patients had fewer cardiac events with a new reversible oral anti-platelet drug compared to standard treatment with an irreversible... More »
|
|
Houston Business Journal - Nov. 15, 2009
|
| American Heart Association Late-Breaking Clinical Trial... |
|
Companies mentioned in this article: American Heart Association Study highlights: -STEMI (heart attack) patients had fewer cardiac events with a new reversible oral... More »
|
|
Freshnews.com - Nov. 15, 2009
|
| American Heart Association Late-Breaking Clinical Trial... |
|
Study highlights: -STEMI (heart attack) patients had fewer cardiac events with a new reversible oral anti-platelet drug compared to standard treatment with an irreversible... More »
|
|
Forbes.com - Nov. 15, 2009
|